Особенности факохирургии при макулярной патологии. Часть 2. Возможности оптической коррекции

Катаракта и возрастная макулярная дегенерация (ВМД) являются ведущими причинами слепоты во всем мире. Основными симптомами ВМД являются постепенное снижение остроты зрения до сотых, метаморфопсии, появление центральной скотомы, что снижает качество жизни пациента и приводит к инвалидности. Портативные и стационарные средства оптической реабилитации, такие как лупы для слабовидящих, очки, видеосистемы, громоздки и малофункциональны. Альтернативным вариантом коррекции являются интраокулярные зрительные устройства, позволяющие улучшить качество жизни пациента. В обзоре рассмотрены различные виды интраокулярных имплантатов, в частности система интраокулярного телескопа (интраокулярный миниатюрный телескоп IMT, IOL-VIP, IOL-AMD), линза Френеля, линза Липшица, макулярная линза Scharioth (Scharioth macula lens, SML), EyeMax Mono, ИОЛ LENTIS ® MAX LS-313 MF80. Применение высокотехнологичных устройств для коррекции зрительных нарушений при ВМД открыло новое направление в реабилитации слабовидения. Дальнейшее изучение и внедрение в практику «макулярных» линз последнего поколения позволит повысить качество жизни пациентов с далекозашедшими стадиями ВМД.

1. Age-Related Macular Degeneration PPP — Updated 2015 (2015). http://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015. Accessed January 2015.

2. Schmidt-Erfurth U., Chong V., Loewenstein A., Larsen M., Souied E., Schlingemann R., Eldem B., Monés J., Richard G., Bandello F. European Society of Retina Specialists. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) Br J Ophthalmol. 2014;98(9):1144–1167. DOI: 10.1136/bjophthalmol-2014-305702.22

3. Mönestam E., Lundqvist B. Long-term visual outcome after cataract surgery: comparison of healthy eyes and eyes with age-related macular degeneration. J Cataract Refract Surg. 2012;38(3):409–414. DOI: 10.1016/j.jcrs.2011.09.041

4. Kessel L., Erngaard D., Flesner P., Andresen J., Tendal B., Hjortdal J. Cataract surgery and age-related macular degeneration. An evidence-based update. Acta Ophthalmol. 2015;93(7):593–600. DOI: 10.1111/aos.12665

5. Van Norren D., Vos J.J. Light damage to the retina: an historical approach. Eye. 2016;30(2):169–172. DOI: 10.1038/eye.2015

6. Downes S.M. Ultraviolet or blue-filtering intraocular lenses: what is the evidence? Eye. 2016;30(2):215–221. DOI: 10.1038/eye.2015.267

7. Steinemann A., Bromundt V., Chellappa S.L., Frey S., Schmidt C., Schlote T., Goldblum D., Cajochen C. Evaluation of Visual Comfort and Mental Effort Under Different Light Conditions for Ultraviolet-Absorbing and Additional Blue-Filtering Intraocular Lenses for Cataract Surgery. Klin Monbl Augenheilkd. 2019;236(4):398–404. DOI: 10.1055/a-0810-0302

8. Armbrecht A.M., Findlay C., Aspinall P.A. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg. 2003;29:686–693. DOI: 10.1111/aos.12665

9. Žiak P., Halička J., Mojžiš Р. Presbyopic lens exchange (PRELEX) cataract surgery outcomes with implantation of a rotationally asymmetric refractive multifocal intraocular lens: femtosecond laser-assisted versus manual phacoemulsification. International ophthalmology. 2019;39(12):2875–2882. DOI: 10.1007/s10792-01901135-3

10. Grzybowski A., Kanclerz P., Tuuminen R. Multifocal intraocular lenses and retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2020;258(4):805–813. DOI: 10.1007/s00417-020-04603-0

11. Будзинская М.В. Возрастная макулярная дегенерация. Вестник офтальмологии. 2014;130(6):56–61.

12. Gopalakrishnan S., Velu S., Raman R. Low-vision intervention in individuals with age-related macular degeneration. Indian J Ophthalmol. 2020;68(5):886–889. DOI: 10.4103/ijo.IJO_1093_19

13. Dandona L., Dandona R. Revision of visual impairment definitions in the international statistical classification of diseases. BMC Med. 2006; 2006;4:7.

14. Gopalakrishnan S., Muralidharan A., Susheel S.C., Raman R. Improvement in distance and near visual acuities using low vision devices in diabetic retinopathy. Indian J Ophthalmol. 2017;65:995–998. DOI: 10.4103/ijo. IJO_52_17

15. Das K., Gopalakrishnan S., Dalan D., Velu S., Ratra V., Ratra D. Factors influencing the choice of low vision devices for visual rehabilitation in Stargardt disease. Clin Exp Optom. 2019;102:426–433. DOI: 10.1111/cxo.12867

16. Altpeter E.K., Nguyen N.X. Requirements for low vision magnification aids imagerelated macular degeneration: data from the Tübingen low vision clinic (comparison of 2007–2011 with 1999–2005) Ophthalmologe. 2015;112(11):923–928. DOI: 10.1007/s00347-015-0062-2

17. Roach L. 5-year results with implanted telescope. EyeNet. 2015;17–18.

18. Lazarou J. Implantable Telescope Lens to Treat Macular Degeneration. Available online: Johns Hopkins. www.hopkinsmedicine.org/news/media/releases/implantable_telescope_lens_to_treat_macular_degeneration_available_at_johns_hopkins. Accessed 21 March 2013.

19. Dunbar H.M.P., Dhawahir-Scala F.E. A Discussion of Commercially Available Intra-Ocular Telescopic Implants for Patients with Age-Related Macular Degeneration. Ophthalmol Ther 2018;7:33–48. DOI: 10.1007/s40123-018-0129-7

20. Alió J.L., Mulet E.M., Ruiz J.M., Sánchez M.J., Galal A. Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg. 2004;30:1177–1189. DOI: 10.1016/j.jcrs.2003.10.038

21. Hudson H.L., Lane S.S., Heier J.S., Stulting R.D., Singerman L., Lichter P.R., Sternberg P., Chang D.F. Implantable miniature telescope for the treatment of visual acuity loss due to end-stage age-related macular degeneration: one-year results. Ophthalmology. 2006;113:1987–2001. DOI: 10.1016/j.ophtha.2006.07.010

22. Hudson H.L., Stulting R.D., Heier J.S., Lane S.S., Chang D.F., Singerman L.J., Bradford C.A., Leonard R.E., IMT002 Study Group Implantable telescope for end-stage age-related macular degeneration. Long-term visual acuity and safety outcomes. Am J Ophthalmol. 2008;146:664–673. DOI: 10.1016/j.ajo.2008.07.003

23. Singer M.A., Amir N., Herro A., Porbandarwalla S.S., Pollard J. Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants. Clin Ophthalmol. 2012;6:33–39. DOI: 10.2147/OPTH.S15028

24. Boyer D., Freund K.B., Regillo C., Levy M.H., Garg S. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015;9:1099–1107. DOI: 10.2147/OPTH.S86208

25. Dag M.Y., Afrashi F., Nalcaci S. The efficacy of “IOL-Vip Revolution” telescopic intraocular lens in age-related macular degeneration cases with senile cataract. Eur J Ophthalmol. 2019;29:615–620. DOI: 10.1177/1120672118803831

26. Savaresi G., Pierrottet C.O., Orzalesi N. The IOL-Vip® Software: guidelines for IOLVip® implant. Invest Ophthalmol Vis Sci. 2004;45:2010.

27. Orzalesi N., Pierrottet C.O., Zenoni S., Savaresi C. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology. 2007;114(5):860–865. DOI: 10.1016/j.ophtha.2007.01.005

28. Hengerer F.H. Sutureless telescopic IOL for patients with dry AMD. Cataract Refract Surg Today Eur. 2015;2:40–41. DOI: 10.3928/1081597X-20150220-03

29. Potgieter F.J., Claoue C.M. Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: initial clinical experience. J Cataract Refract Surg. 2014;40(7):1085–1091. DOI: 10.1016/j.jcrs.2013.10.049

30. Lipshitz I., Jacob S., Lamba M., Tiwari R., Kumar D.A., Agarwal A. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34(1):87–94. DOI: 10.1016/j.jcrs.2007.08.031

31. Agarwal A., Lipshitz I., Jacob S., Lamba M., Tiwari R., Kumar D.A., Agarwal A. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008;34(1):87–94. DOI: 10.1016/j.jcrs.2007.08.031

32. Grzybowski A.., Wasinska-Borowiec W., Alio J.L. Intraocular lenses in age-related macular degeneration. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2017;255(9):1687–1696. DOI: 10.1007/s00417-017-3740-8

33. Scharioth G.B. New add-on intraocular lens for patients with age-related macular degeneration. J Cataract Refract Surg. 2015;41(8):1559–1563. DOI: 10.1016/j.jcrs.2015.07.018

34. Бикбов М.М., Бурханов Ю.К., Оренбуркина О.И., Бабушкин А.Э. Реабилитация пациентов с артифакией и возрастной макулярной дегенерацией путем имплантации добавочной макулярной линзы Шариота (первый российский опыт). Современные технологии в офтальмологии. 2018;3:20–22. DOI: 10.18008/1816-5095-2019-1S-7-11

35. Srinivasan S. Implantation of Scharioth macula lens in patients with age-related macular degeneration: results of a prospective European multicentre clinical trial [published correction appears in BMJ Open Ophthalmol. 2019 Aug 9;4(1):e000322corr1]. BMJ Open Ophthalmol. 2019;4(1):000322. Published 2019 Jul 7. DOI: 10.1136/bmjophth-2019-000322

36. Nielsen Niels V., Helgesen A., Muus G. Scharioth Macula Lens for AMD: Quality of Life Study. Presented at: European Society of Cataract and Refractive Surgeons meeting, Vienna, Austria, September 22-26, 2018.

37. Borkenstein A.F., Borkenstein E.M. Cataract surgery with implantation of a highadd intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: A case report of magnifying surgery. Clin Case Rep. 2018;7(1):74–78. DOI: 10.1002/ccr3.1912

38. Borkenstein A.F., Borkenstein E.M. Four Years of Observation to Evaluate Autonomy and Quality of Life after Implantation of a High-Add Intraocular Lens in AgeRelated Macular Degeneration Patients. Case Rep Ophthalmol. 2020;11(2):448–456. DOI: 10.1159/000508914

39. Qureshi M.A., Robbie S.J., Hengerer F.H. Consecutive case series of 244 age-related macular degeneration patients undergoing implantation with an extended macular vision IOL. Eur J Ophthalmol 2018;28:198–203. DOI: 10.5301/ejo.5001052

40. Grzybowski A., Wang J., Mao F., Wang D., Wang N. Intraocular vision-improving devices in age-related macular degeneration. Ann Transl Med. 2020;8(22):1549. DOI: 10.21037/atm-20-5851